Addressing Social Determinants of Health in Hidradenitis Suppurativa Care

Panelist discusses how social determinants of health create significant diagnostic barriers for hidradenitis suppurativa through systemic inequities, limited health care access, and provider knowledge gaps. Health systems can mitigate these challenges through targeted educational, technological, and culturally responsive interventions.

EP: 1.Bridging the Gap in Recognizing Early Symptoms of Hidradenitis Suppurativa

EP: 2.Improving HS Diagnosis and Care Through Better Alignment of Staging and Severity

Now Viewing

EP: 3.Addressing Social Determinants of Health in Hidradenitis Suppurativa Care

EP: 4.Economic Implications of Diagnostic Delays in Hidradenitis Suppurativa

EP: 5.Strategies for Equitable Access in Hidradenitis Suppurativa

EP: 6.Partnering With Patient Advocacy Groups to Improve HS Awareness and Outcomes

EP: 7.Holistic Care for HS Patients: The Power of Multidisciplinary Models

EP: 8.The Case for HS Centers of Excellence: Evidence for Improved Patient Outcomes

EP: 9.Innovating HS Care: Applying Multidisciplinary Lessons to Diagnosis and Management

EP: 10.The Value Proposition: Justifying the Investment in HS Centers of Excellence

EP: 11.Key Takeaways on HS Care: Multidisciplinary Collaboration and Equity Solutions

Video content above is prompted by the following:

• How do social determinants of health create barriers to timely and accurate diagnosis of HS?
• What strategies can health systems implement to mitigate these barriers?

Related Videos

Related Content

Advertisement

March 12th 2025

Frailty, Housing Instability Drive Mortality Risk in People With HIV

Brooke McCormick

These abstracts highlight the compounded challenges people with HIV face.

December 23rd 2024

Five Years Later: Ongoing COVID-19 Challenges, Next Steps

Brooke McCormick

On this episode of Managed Care Cast, we speak with Jenny Han, MD, of Emory School of Medicine and Grady Hospital, about COVID-19, long COVID, and strategies for prevention and care.

March 11th 2025

Overdiagnosis of Adult ADHD Is Exacerbating the Stimulant Shortage

Salayna M. Abdallah, MA, BS Bryce L. Tipton, BS Joel W. Hughes, PhD

The authors argue that the stimulant shortage is being perpetuated by the overdiagnosis of attention-deficit/hyperactivity disorder (ADHD) in adults because executive functioning deficits are not included in diagnostic criteria.

December 17th 2024

Diving Into Patient Preferences for Blood Cancer Treatments With Dr Sikander Ailawadhi

Three abstracts presented at the 2024 American Society of Hematology annual meeting focused on patient preferences and treatment choices in blood cancers.

March 9th 2025

Reviving the Classics: The Role of Older Medications in Modern Dermatology

Brooke McCormick

Older, generic medications, including ones for cyclosporine, nicotinamide, and dapsone, can effectively treat patients with various dermatological conditions while helping to reduce insurance and cost barriers.

March 9th 2025

Higher Dietary Fiber Intake Associated With Lower Osteoarthritis Risk

Brooke McCormick

A dietary fiber intake between 14.4 and 26.7 g reduced the risk of osteoarthritis, but an intake above this dose was not significantly protective.

Related Content

Advertisement

March 12th 2025

Frailty, Housing Instability Drive Mortality Risk in People With HIV

Brooke McCormick

These abstracts highlight the compounded challenges people with HIV face.

December 23rd 2024

Five Years Later: Ongoing COVID-19 Challenges, Next Steps

Brooke McCormick

On this episode of Managed Care Cast, we speak with Jenny Han, MD, of Emory School of Medicine and Grady Hospital, about COVID-19, long COVID, and strategies for prevention and care.

March 11th 2025

Overdiagnosis of Adult ADHD Is Exacerbating the Stimulant Shortage

Salayna M. Abdallah, MA, BS Bryce L. Tipton, BS Joel W. Hughes, PhD

The authors argue that the stimulant shortage is being perpetuated by the overdiagnosis of attention-deficit/hyperactivity disorder (ADHD) in adults because executive functioning deficits are not included in diagnostic criteria.

December 17th 2024

Diving Into Patient Preferences for Blood Cancer Treatments With Dr Sikander Ailawadhi

Three abstracts presented at the 2024 American Society of Hematology annual meeting focused on patient preferences and treatment choices in blood cancers.

March 9th 2025

Reviving the Classics: The Role of Older Medications in Modern Dermatology

Brooke McCormick

Older, generic medications, including ones for cyclosporine, nicotinamide, and dapsone, can effectively treat patients with various dermatological conditions while helping to reduce insurance and cost barriers.

March 9th 2025

Higher Dietary Fiber Intake Associated With Lower Osteoarthritis Risk

Brooke McCormick

A dietary fiber intake between 14.4 and 26.7 g reduced the risk of osteoarthritis, but an intake above this dose was not significantly protective.